{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T01:13:09Z","timestamp":1785287589259,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:00:00Z","timestamp":1612310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:00:00Z","timestamp":1612310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s10620-021-06857-y","type":"journal-article","created":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T14:03:32Z","timestamp":1612361012000},"page":"224-232","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Effects of Proton Pump Inhibitors on the Small Bowel and Stool Microbiomes"],"prefix":"10.1007","volume":"67","author":[{"given":"Stacy","family":"Weitsman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya","family":"Celly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchi","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashin","family":"Sedighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian M.","family":"Barlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maritza","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Parodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jesus","family":"Villanueva-Millan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Rezaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0619-5115","authenticated-orcid":false,"given":"Mark","family":"Pimentel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,3]]},"reference":[{"key":"6857_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1756284818777943","volume":"11","author":"OO Halfdanarson","year":"2018","unstructured":"Halfdanarson OO, Pottegard A, Bjornsson ES et al. Proton-pump inhibitors among adults: a nationwide drug-utilization study. Ther Adv Gastroenterol. 2018;11:1\u201311","journal-title":"Ther Adv Gastroenterol"},{"key":"6857_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2042098618809927","volume":"10","author":"M Jaynes","year":"2019","unstructured":"Jaynes M, Kumar AB. The risks of long-term use of proton pump inhibitors: a critical review. Ther Adv Drug Saf. 2019;10:1\u201313","journal-title":"Ther Adv Drug Saf"},{"issue":"682\u2013691","key":"6857_CR3","doi-asserted-by":"publisher","first-page":"e682","DOI":"10.1053\/j.gastro.2019.05.056","volume":"157","author":"P Moayyedi","year":"2019","unstructured":"Moayyedi P, Eikelboom JW, Bosch J et al. Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin. Gastroenterology. 2019;157:e682","journal-title":"Gastroenterology"},{"key":"6857_CR4","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/ajg.2012.179","volume":"107","author":"S Janarthanan","year":"2012","unstructured":"Janarthanan S, Ditah I, Adler DG, Ehrinpreis MN. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis. Am J Gastroenterol. 2012;107:1001\u20131010","journal-title":"Am J Gastroenterol"},{"key":"6857_CR5","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.cgh.2009.12.022","volume":"8","author":"L Lombardo","year":"2010","unstructured":"Lombardo L, Foti M, Ruggia O, Chiecchio A. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy. Clin Gastroenterol Hepatol. 2010;8:504\u2013508","journal-title":"Clin Gastroenterol Hepatol"},{"key":"6857_CR6","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/nmo.12516","volume":"27","author":"A Erdogan","year":"2015","unstructured":"Erdogan A, Rao SS, Gulley D, Jacobs C, Lee YY, Badger C. Small intestinal bacterial overgrowth: duodenal aspiration vs glucose breath test. Neurogastroenterol Motil. 2015;27:481\u2013489","journal-title":"Neurogastroenterol Motil"},{"key":"6857_CR7","first-page":"1334","volume":"57","author":"M Pimentel","year":"2008","unstructured":"Pimentel M. The prevalence of small intestinal bacterial overgrowth in irritable bowel syndrome: IBS vs healthy controls (not historical definitions). Gut. 2008;57:1334\u20131335 (author reply 1335).","journal-title":"Gut"},{"key":"6857_CR8","first-page":"139","volume":"52","author":"M Majewski","year":"2007","unstructured":"Majewski M, McCallum RW. Results of small intestinal bacterial overgrowth testing in irritable bowel syndrome patients: clinical profiles and effects of antibiotic trial. Adv Med Sci. 2007;52:139\u2013142","journal-title":"Adv Med Sci"},{"key":"6857_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.15403\/jgld.2014.1121.252.iwg","volume":"25","author":"A Fialho","year":"2016","unstructured":"Fialho A, Fialho A, Thota P, McCullough AJ, Shen B. Small intestinal bacterial overgrowth is associated with non-alcoholic fatty liver disease. J Gastrointest Liver Dis. 2016;25:159\u2013165","journal-title":"J Gastrointest Liver Dis"},{"key":"6857_CR10","doi-asserted-by":"publisher","first-page":"13999","DOI":"10.3748\/wjg.v20.i38.13999","volume":"20","author":"C Sanchez-Montes","year":"2014","unstructured":"Sanchez-Montes C, Ortiz V, Bastida G et al. Small intestinal bacterial overgrowth in inactive Crohn\u2019s disease: influence of thiopurine and biological treatment. World J Gastroenterol. 2014;20:13999\u201314003","journal-title":"World J Gastroenterol"},{"key":"6857_CR11","doi-asserted-by":"publisher","first-page":"190","DOI":"10.14309\/ajg.0000000000000504","volume":"115","author":"A Shah","year":"2020","unstructured":"Shah A, Talley NJ, Jones M et al. Small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis of case-control studies.  Am J Gastroenterol. 2020;115:190\u2013201","journal-title":"Am J Gastroenterol"},{"key":"6857_CR12","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1007\/s10620-006-9306-y","volume":"51","author":"I Nastaskin","year":"2006","unstructured":"Nastaskin I, Mehdikhani E, Conklin J, Park S, Pimentel M. Studying the overlap between IBS and GERD: a systematic review of the literature.  Dig Dis Sci. 2006;51:2113\u20132120. https:\/\/doi.org\/10.1007\/s10620-006-9306-y.","journal-title":"Dig Dis Sci"},{"key":"6857_CR13","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.1111\/j.1572-0241.2008.01992.x","volume":"103","author":"BM Spiegel","year":"2008","unstructured":"Spiegel BM, Chey WD, Chang L. Bacterial overgrowth and irritable bowel syndrome: unifying hypothesis or a spurious consequence of proton pump inhibitors? Am J Gastroenterol. 2008;103:2972\u20132976","journal-title":"Am J Gastroenterol"},{"key":"6857_CR14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12866-019-1617-1","volume":"19","author":"GGS Leite","year":"2019","unstructured":"Leite GGS, Morales W, Weitsman S et al. Optimizing microbiome sequencing for small intestinal aspirates: validation of novel techniques through the REIMAGINE study.  BMC Microbiol. 2019;19:239","journal-title":"BMC Microbiol"},{"key":"6857_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-020-06173-x","author":"GGS Leite","year":"2020","unstructured":"Leite GGS, Weitsman S, Parodi G et al. Mapping the segmental microbiomes in the human small bowel in comparison with stool: a REIMAGINE Study. Dig Dis Sci. 2020. https:\/\/doi.org\/10.1007\/s10620-020-06173-x.","journal-title":"Dig Dis Sci"},{"key":"6857_CR16","doi-asserted-by":"publisher","first-page":"e0234906","DOI":"10.1371\/journal.pone.0234906","volume":"15","author":"G Leite","year":"2020","unstructured":"Leite G, Morales W, Weitsman S et al. The duodenal microbiome is altered in small intestinal bacterial overgrowth.  PLoS ONE. 2020;15:e0234906","journal-title":"PLoS ONE"},{"key":"6857_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gks808","volume":"41","author":"A Klindworth","year":"2013","unstructured":"Klindworth A, Pruesse E, Schweer T et al. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Res. 2013;41:1","journal-title":"Nucleic Acids Res"},{"key":"6857_CR18","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/ajg.2017.46","volume":"112","author":"A Rezaie","year":"2017","unstructured":"Rezaie A, Buresi M, Lembo A et al. Hydrogen and methane-based breath testing in gastrointestinal disorders: the North American consensus.  Am J Gastroenterol. 2017;112:775\u2013784","journal-title":"Am J Gastroenterol"},{"key":"6857_CR19","unstructured":"Pimentel M, Saad RJ, Long MD, Rao SSC. ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth Am J Gastroenterol. 9000; E-published Ahead of Print."},{"key":"6857_CR20","doi-asserted-by":"publisher","first-page":"e1003531","DOI":"10.1371\/journal.pcbi.1003531","volume":"10","author":"PJ McMurdie","year":"2014","unstructured":"McMurdie PJ, Holmes S. Waste not, want not: why rarefying microbiome data is inadmissible. PLoS Comput Biol. 2014;10:e1003531","journal-title":"PLoS Comput Biol"},{"key":"6857_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40168-017-0237-y","volume":"5","author":"S Weiss","year":"2017","unstructured":"Weiss S, Xu ZZ, Peddada S et al. Normalization and microbial differential abundance strategies depend upon data characteristics.  Microbiome. 2017;5:27","journal-title":"Microbiome"},{"key":"6857_CR22","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1038\/ismej.2015.235","volume":"10","author":"S Weiss","year":"2016","unstructured":"Weiss S, Van Treuren W, Lozupone C et al. Correlation detection strategies in microbial data sets vary widely in sensitivity and precision.  ISME J. 2016;10:1669\u20131681","journal-title":"ISME J"},{"key":"6857_CR23","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1001\/jamainternmed.2013.14673","volume":"174","author":"R MacLaren","year":"2014","unstructured":"MacLaren R, Reynolds PM, Allen RR. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit. JAMA Intern Med. 2014;174:564\u2013574","journal-title":"JAMA Intern Med"},{"key":"6857_CR24","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13054-016-1305-6","volume":"20","author":"F Alshamsi","year":"2016","unstructured":"Alshamsi F, Belley-Cote E, Cook D et al. Efficacy and safety of proton pump inhibitors for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis of randomized trials.  Crit Care. 2016;20:120","journal-title":"Crit Care"},{"key":"6857_CR25","doi-asserted-by":"publisher","first-page":"178","DOI":"10.4103\/2319-4170.128002","volume":"37","author":"S Biswal","year":"2014","unstructured":"Biswal S. Proton pump inhibitors and risk for Clostridium difficile associated diarrhea.  Biomed J. 2014;37:178\u2013183","journal-title":"Biomed J"},{"key":"6857_CR26","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1017\/ice.2016.194","volume":"37","author":"V Arriola","year":"2016","unstructured":"Arriola V, Tischendorf J, Musuuza J, Barker A, Rozelle JW, Safdar N. Assessing the risk of hospital-acquired clostridium difficile infection with proton pump inhibitor use: a meta-analysis.  Infect Control Hosp Epidemiol. 2016;37:1408\u20131417","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"413\u2013419","key":"6857_CR27","first-page":"e298","volume":"25","author":"RS Choung","year":"2013","unstructured":"Choung RS, Locke GR, Schleck CD, Zinsmeister AR, Talley NJ. Associations between medication use and functional gastrointestinal disorders: a population-based study.  Neurogastroenterol Motil. 2013;25:e298","journal-title":"Neurogastroenterol Motil"},{"issue":"883\u2013885","key":"6857_CR28","first-page":"e889","volume":"149","author":"DE Freedberg","year":"2015","unstructured":"Freedberg DE, Toussaint NC, Chen SP et al. Proton pump inhibitors alter specific taxa in the human gastrointestinal microbiome: a crossover trial.  Gastroenterology. 2015;149:e889","journal-title":"Gastroenterology"},{"key":"6857_CR29","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1007\/s10620-018-5122-4","volume":"63","author":"M Hojo","year":"2018","unstructured":"Hojo M, Asahara T, Nagahara A et al. Gut microbiota composition before and after use of proton pump inhibitors.  Dig Dis Sci. 2018;63:2940\u20132949. https:\/\/doi.org\/10.1007\/s10620-018-5122-4.","journal-title":"Dig Dis Sci"},{"key":"6857_CR30","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41467-019-14177-z","volume":"11","author":"A Vich Vila","year":"2020","unstructured":"Vich Vila A, Collij V, Sanna S et al. Impact of commonly used drugs on the composition and metabolic function of the gut microbiota.  Nat Commun. 2020;11:362","journal-title":"Nat Commun"},{"key":"6857_CR31","doi-asserted-by":"publisher","first-page":"104578","DOI":"10.1016\/j.archoralbio.2019.104578","volume":"109","author":"S Liu","year":"2020","unstructured":"Liu S, Chen M, Wang Y et al. Effect of Veillonella parvula on the physiological activity of Streptococcus mutans.  Arch Oral Biol. 2020;109:104578","journal-title":"Arch Oral Biol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-06857-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-021-06857-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-06857-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T19:46:46Z","timestamp":1641584806000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-021-06857-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,3]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["6857"],"URL":"https:\/\/doi.org\/10.1007\/s10620-021-06857-y","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,3]]},"assertion":[{"value":"10 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}